Health Canada Standard Processing License Provides Advantage for Cannabis Extraction and Vertical Integration Biotech Investing
Isodiol International Inc. Announces Acquisition of Food Labs, Inc. and Strategic Investor Relationship with Toba Capital LLC Cannabis Investing News
Kalytera Provides Update on Phase 2 Clinical Study Evaluating CBD in Prevention of Acute GVHD Biotech Investing
Mustang Bio Receives Orphan Drug Designation for MB-102 (CD123 CAR T) for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm Pharmaceutical Investing
Amicus Therapeutics Announces First Patient Dosed in Phase 3 PROPEL Pivotal Study of AT-GAA in Patients with Pompe Disease Biotech Investing
FibroGen Announces Positive Topline Results from Three Global Phase 3 Trials of Roxadustat Pharmaceutical Investing
DBV Technologies Provides Update on Viaskin Peanut for Children Four to 11 Years of Age Biotech Investing
Clearside Biomedical Submits New Drug Application for XIPERE for the Treatment of Macular Edema Associated with Uveitis Pharmaceutical Investing
G1 Therapeutics Announces Positive Topline Results from Randomized Phase 2 Trial of Trilaciclib Pharmaceutical Investing
